Bmc Nephrol
-
Clinical Trial Observational Study
suPAR as a marker of infection in acute kidney injury - a prospective observational study.
Soluble urokinase-type plasminogen activator receptor (suPAR) has emerged as a new sepsis biomarker. It is not known whether suPAR has a role in critically ill patients with severe acute kidney injury (AKI). ⋯ In critically ill patients with AKI stage 2/3, suPAR is a better marker of infection than CRP.